Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.

导出原文传递

翻译打印收藏纠错

作者： Ting,Wang ^[1] ; Yunxiang,Tang ^[2] ; Yang,Yang ^[1] ; Qi,An ^[1] ; Zitai,Sang ^[1] ; Tao,Yang ^[1] ; Pingxian,Liu ^[1] ; Tianyu,Zhang ^[3] ; Yong,Deng ^[4] ; Youfu,Luo ^[5]

作者单位： Department of Medicinal Chemistry, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China. ^[1] Institute of Physical Science and Information Technology, Anhui University, Hefei 230039, China. ^[2] State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510000, China. ^[3] Department of Medicinal Chemistry, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: dengyong@scu.edu.cn. ^[4] Department of Medicinal Chemistry, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: luo_youfu@scu.edu.cn. ^[5]

关键词 Antituberculosis InhA inhibitors Pyrrolo[1,2-a]quinoxaline XBBXBJCTTIAVDA-UHFFFAOYSA-N